Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Pilot Study of Lestaurtinib (CEP-701) in Combination with Chemotherapy in Young Patients with Relapsed or Refractory FLT3-mutant Acute Myeloid LeukemiaCIRB: Pediatric CIRBLead Group: COGStatus: CompletedReview Status: Completed
